Thank you for joining Winchester’s Managing Director, Michael O. Regentz, CSI (IIE), CeBSA (IBM), in a timely discussion that revealed new information about the impact of Adaptive Clinical Trials on eClinical systems. You may replay the entire Webinar OR download just the slide presentation.
